Special Article - Brain Injury Medicine
J Pediatr & Child Health Care. 2018; 3(1): 1024.
Rehabilitation Medicine NHS/BSRM -UK
*Corresponding author: M.A Ali, DRehabilitation Medicine NHS/BSRM -UK
Received: September 19, 2018; Accepted: September 25, 2018; Published: October 02, 2018
To improve the In-patient Spasticity services at CERU (Cen Unit), UK
We do inject our patients with Botulinum Toxin for their spa limbs following their neurological illness, (e.g., following tra Multiple Sclerosis other neurological illnesses). To improve the multidisciplinary team and to improve the functional Ou management, now we developed a multidisciplinary approach includes them being seen in the ward round by the multidisc them for their spasticity together and make a management their goals in mind. We designed a Performa for each patient management to be filled via MDT approach and be reviewed.
We developed a multidisciplinary approach for these patient being seen in the ward round by the multidisciplinary team spasticity together and make a management plan according mind. We designed a Performa for each patient who needs filled via MDT approach and be reviewed accordingly.
The timescale for this project was from October 2015 to Ja audit to make sure we achieved the goals and made the se implemented accordingly.
This service development plan improved our patient’s man as was measured through feedback and an audit. The mule the spasticity management showed an improvement in Ou magement with a better review plan in place as well with communication.
Overall the lack of high quality evaluations of medications f agitation and/aggression in patients with ABI. Beta block both agitation and aggression with no difference between Recommendations are completeness of behavioural charts the evaluation but also to document response to intervention.
Measures remains the priority but monitoring of drug side pharmacological intervention.